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SCIENTIFIC PUBLISHING
Transparent reporting of
research results in eLife
Manuscripts should include all the experimental and statistical details
that are needed to replicate the experiments and analyses reported in
them.
G
rowing concerns about a lack of repro-
ducibility in certain areas of biomedical
research have led to several initiatives
to improve the design of experiments, the analy-
sis of data, and the reporting of methods and
results (Ioannidis, 2014). Two popular
approaches to improving the reliability of pub-
lished research results have been the pre-regis-
tration of experimental protocols and analysis
plans, and the introduction of transparent-
reporting forms by journals. Such forms are the
focus of this editorial.
Pre-registration means that experimental pro-
tocols and analysis plans, including blinding and
randomisation procedures, are published before
any experiments are performed. This is done to
reduce bias, to prevent inappropriate post hoc
statistical analysis, and to facilitate replication
(Chambers and Munafo, 2013; Nosek et al.,
2015). The pre-registration approach has evolved
to work well in randomised clinical trials and it
provides an essential foundation for the system-
atic reviews that drive evidence-based medicine.
Although a workable framework for pre-regis-
tration has yet to emerge for basic science and
preclinical studies, various journals have already
introduced procedures and checklists to ensure
that submitted manuscripts contain all the infor-
mation an editor, reviewer or reader needs in
order to assess the reliability of the results or
repeat the experiments (see, for example,
Nature, 2013; McNutt, 2014; van Noorden,
2014). These journal-specific reporting forms are
to be used in conjunction with established report-
ing guidelines that cover specific types of studies
(such as randomised trials, observational studies,
systematic reviews and so on: see
Equator Network, 2016). This editorial
describes the four elements in the transparent
reporting form that was introduced by eLife last
August; authors are required to complete this
form before their manuscript is sent for peer
review.
Sample size estimation: One of the biggest
challenges encountered when planning an
experiment is to estimate the number of meas-
urements that are required to ensure that the
experiment stands a good chance of giving a
definitive answer to the question it was designed
to address. This number, which is known as the
sample size, depends on a number of different
factors, including the size of the effect that the
researcher expects to see. The lack of any justifi-
cation of the sample sizes used in experiments is
a serious problem in many fields of science, and
is a common weakness that has been picked up
in a number of recent systematic reviews
(Henderson et al., 2015). Estimating the effect
size is perhaps the most challenging part of esti-
mating the sample size needed for the experi-
ment (Masca et al., 2015). Further guidance on
how to estimate required sample sizes is avail-
able in a number of places (see Box 1: Further
Resources). It is also important for researchers to
take into account the fact that some measure-
ments and/or replicates will fail and, therefore,
to increase the initial sample size to counter this.
The eLife transparent reporting form asks
authors to state where information about sample
sizes (which should include details of the meth-
ods used to estimate them and the assumptions
made) can be found in their manuscript, or to
explain why this information does not apply to
their submission.
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Replicates. The structure of the experiment in
terms of how the individual measurements are
processed and transformed (including replicated
stages) should be presented clearly as a pipeline
so that other researchers can replicate the full
experiment and understand the statistical analy-
sis. This should include clear rules for the exclu-
sion of samples and the identification of outliers.
Statistical reporting. Sufficient details need to
be provided within the manuscript for full trans-
parency and replication. The number of meas-
urements and the unit of analysis should be clear
for each statistical hypothesis test. The informa-
tive display of raw data is also encouraged.
When sample sizes are small (N<20 per group),
raw data should be displayed graphically rather
than as summary statistics. And wherever possi-
ble, estimated effect sizes (for example, the dif-
ference between two means) should be
reported along with 95% confidence intervals, in
addition to p-values.
Additional data files ("source data"). This com-
pletes the process of transparency. Raw data
and the basic statistical processing scripts used
to analyze them can be made available in a num-
ber of ways (for example, via the paper itself,
GitHub or the Centre for Open Science).
By thinking more carefully and thoroughly
about issues like sample sizes, replicates and sta-
tistical analysis, by reporting the results of these
considerations more fully, and by making data
and code available, researchers will increase the
confidence of other researchers and the wider
world in the robustness and reliability of their
published work.
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Box 1. Further resources
Guidance on how to estimate sample sizes is available from a number of organizations:
Equator Network. http://www.equator-network.org
Medical Research Council: Cognition and Brain Sciences Unit. http://imaging.mrc-cbu.cam.
ac.uk/statswiki/FAQ/effectSize
National Centre for the Replacement, Refinement and Reduction of Animals in Research
(NC3Rs). https://www.nc3rs.org.uk/experimental-design
National Institutes of Health. https://www.nih.gov/research-training/rigor-reproducibility/
principles-guidelines-reporting-preclinical-research
The eLife transparent reporting form is available in both Word and pdf formats.
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